Dosimetric Comparison of Simultaneous Integrated Boost Regimen Using Flexible Inflatable Multi-Channel Versus Single Channel Vaginal Applicator in the Management of Gynecologic Cancer

overall survival (2-yr overall survival 94% vs 63%, p50.002) following definitive salvage therapy. Conclusions: Salvage image-based HDRB shows excellent tumor control and acceptable morbidity for vaginal recurrences of endometrial cancer. Anticipated salvage rates must be taken in the context of primary risk factors including the widely quoted salvage rates from PORTEC 1 which included primarily intermediate risk stage I patients.